However, the observed trends in IgG and IgA response in pARD after vaccination, with antibodies first decreasing over time as expected, and then increasing again six months after the vaccination, suggest that patients had been exposed to SARS-CoV-2 but did not experience a symptomatic infection. The gene discussed is CD79A; the disease is infection.